New Analyst Forecast: $CNM Given 'Outperform' Rating

CNM has received an 'Outperform' rating from RBC Capital, adding to the three buy ratings issued by analyst firms in recent months. Congressional members have purchased CNM stock twice in the last six months, while company insiders have sold shares 16 times during the same period. Hedge fund activity shows mixed sentiment, with 199 institutional investors increasing their positions, including D1 CAPITAL PARTNERS L.P. adding 4,945,680 shares, while 263 decreased their positions, including FMR LLC removing 2,266,614 shares.

Analysis

Core & Main, Inc. ($CNM) has received positive coverage from Wall Street analysts, with RBC Capital recently issuing an 'Outperform' rating on June 10, 2025, and both Wells Fargo and Deutsche Bank providing 'Overweight' and 'Buy' ratings respectively in recent months, contributing to a total of three buy ratings and no sell ratings from these firms. This analyst optimism contrasts sharply with significant insider selling activity over the last six months, where 16 sales transactions were recorded with zero purchases. Notably, key executives including the Executive Vice President (selling 111,406 shares for an estimated $5.49 million), General Counsel (selling 100,000 shares for ~$5.28 million), and Chief Accounting Officer (selling 83,927 shares for ~$4.34 million) were among those divesting substantial holdings. While there were two congressional purchases by one representative, REPRESENTATIVE APRIL MCCLAIN DELANEY, totaling up to $30,000 between February and April, these are minor compared to the aggregate volume and value of insider sales. Institutional investor activity for $CNM presents a mixed picture for the most recent quarter: 199 institutional investors added shares, while 263 decreased their positions. Significant new stakes were initiated, such as D1 CAPITAL PARTNERS L.P. acquiring 4.95 million shares (valued at ~$238.9 million in Q1 2025) and MORGAN STANLEY increasing its holding by 3.4 million shares (+47.1% in Q1 2025). Conversely, prominent funds like POINTSTATE CAPITAL LP, CAPITAL INTERNATIONAL INVESTORS, and ZIMMER PARTNERS, LP fully exited their positions in Q4 2024, and FMR LLC reduced its stake by 2.27 million shares (-25.0% in Q1 2025). This divergence between bullish analyst sentiment and substantial insider divestment, coupled with mixed institutional flows and a specific ticker sentiment score of -0.4 for $CNM, suggests a complex outlook requiring careful scrutiny.

Key Decisions for Investors

• Investors should exercise caution regarding $CNM due to the substantial and broad-based insider selling, which presents a conflicting signal against positive analyst ratings and modest congressional buying.
• Closely monitor upcoming institutional ownership filings (Q2 2025 data) and any further insider transaction disclosures to gauge shifts in conviction from sophisticated market participants, particularly noting if new large positions are maintained or if selling pressure from insiders subsides.
• It is prudent to investigate the context of the significant insider sales, such as whether they are part of pre-arranged 10b5-1 trading plans or reflect genuine concerns about the company's valuation or future performance, before fully aligning with the bullish sell-side consensus.